# Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

> **NCT05256693** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 336 (estimated)

## Conditions studied

- Clostridium Difficile Infections
- Stem Cell Transplant Complications

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05256693
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2024-06
- **Final completion:** 2025-07
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05256693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05256693, "Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05256693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*